Combination therapy
Showing 1 - 25 of >10,000
Lymphedema Arm Trial (BioBridge)
Not yet recruiting
- Lymphedema Arm
- BioBridge
- (no location specified)
Apr 20, 2023
Androgenetic Alopecia Trial in Jakarta (Minoxidil 5% Topical Solution, microneedling)
Recruiting
- Androgenetic Alopecia
- Minoxidil 5% Topical Solution
- microneedling
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangungkusumo Hospital
Aug 3, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)
Available
- Paroxysmal Nocturnal Hemoglobinuria
- (no location specified)
Aug 31, 2023
TNFi as Monotherapy or Combination Therapy With MTX and Compare
Completed
- Rheumatoid Arthritis
- patterns of use of combination therapy and monotherapy
-
New York, New YorkPfizer
Oct 7, 2022
Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational
Not yet recruiting
- Metastatic Cancers
- Fatigue
- Psychoeducational Intervention
- +2 more
-
Houston, TexasMD Anderson Cancer Centerr
Oct 10, 2023
Osteoradionecrosis, Osteoradionecrosis of Jaw, Osteoradionecrosis of the Mandible Trial (modified PENTOCLO (mPENTOCLO), sham
Not yet recruiting
- Osteoradionecrosis
- +2 more
- modified PENTOCLO (mPENTOCLO)
- sham mPENTOCLO
- (no location specified)
Sep 19, 2023
Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- combination therapy with no MEKi
- +3 more
- (no location specified)
Nov 29, 2022
Essential Hypertension Trial in Seoul (D064 and D702, QD, D064 and Placebo of D702, QD, Placebo of D064 and D702, QD)
Recruiting
- Essential Hypertension
- D064 and D702, QD
- +2 more
-
Seoul, Seongdong-gu, Korea, Republic ofHanyang University Seoul Hospital
Nov 7, 2023
Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)
Completed
- Thalassemia, Beta
- Hydroxyurea and Thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 23, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)
Not yet recruiting
- Advanced Solid Tumor
- JS015
- +10 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 17, 2023
Non-healing Wound, Non-Healing Ulcer of Skin Trial in Santa Fe (Omeza Products Used in Combination)
Recruiting
- Non-healing Wound
- Non-Healing Ulcer of Skin
- Omeza Products Used in Combination
-
Santa Fe, New MexicoChristus St. Vincent
Jun 19, 2023
Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Carcinoma Trial in Duarte (procedure, drug, other)
Not yet recruiting
- Advanced Prostate Carcinoma
- +4 more
- Bright White Light Therapy
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 8, 2023
Migraine Trial in Dhaka (Topiramate 25Mg Tab, Amitriptyline 25 Mg Oral Tablet, topiramate 25mg plus amitriptyline 25mg)
Enrolling by invitation
- Migraine
- Topiramate 25Mg Tab
- +2 more
-
Dhaka, BangladeshDhaka Medical College
Feb 26, 2023
Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon
Not yet recruiting
- Chronic Hepatitis Delta
- Peginterferon Lambda
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 25, 2023
Primary Condition: Advanced Tumors Trial in Guangzhou (JS009 as a monotherapy and JS009 as a Triple Combination Therapy in
Not yet recruiting
- Primary Condition: Advanced Tumors
- JS009 as a monotherapy and JS009 as a Triple Combination Therapy in Combination with Toripalimab and JS006
-
Blacktown, New South Wales, Australia
- +3 more
Feb 1, 2023
Sarcoma,Soft Tissue, Brachytherapy, Poly(ADP-ribose) Polymerase Inhibitors Trial in Guangzhou (Fluzoparib, Radioactive particle
Recruiting
- Sarcoma,Soft Tissue
- +2 more
- Fluzoparib
- Radioactive particle implantation
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 30, 2023
Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul
Not yet recruiting
- Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
- ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
- high-intensity statin monotherapy (atoravastatin 40mg)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 21, 2023
Malaria Trial in Kasese (Artemether/lumefantrine, Ivermectin)
Recruiting
- Malaria
-
Kasese, UgandaST. Paul's Health Center
Oct 31, 2022